Appendix 2—table 1.
Group 1 Placebo Day 1 |
Group 2 MPH Day 1 |
|||
---|---|---|---|---|
Neuropsychological tests | Listening span | 5.0 (0.9) | 4.6 (1.2) | p=0.16 |
NLV | 94.4 (7.6) | 92.6 (7.6) | p=0.23 | |
Digit span – forward | 17.2 (3.7) | 16.2 (3.6) | p=0.16 | |
Digit Span - backward | 14.7 (3.4) | 13.9 (2.7) | p=0.22 | |
Self-report questionnaires | Impulsivity (BIS-11) | 63.5 (8.9) | 60.2 (7.9) | p=0.052* |
Behavioural inhibition (BIS) | 16.4 (3.7) | 16.3 (3.5) | p=0.90 | |
Behavioural activation (BAS) | 22.8 (3.9) | 23.9 (4.0) | p=0.17 | |
Need for cognition (NCS) | 64.5 (10.5) | 62.2 (10.5) | p=0.26 | |
Social support (MSPSS) | 71.1 (10.1) | 69.3 (9.6) | p=0.35 | |
Social status (BSMSS) | 49.8 (12.1) | 45.9 (12.7) | p=0.11 | |
Social dominance (SADQ) | 4.1 (0.9) | 4.1 (0.8) | p=0.82 | |
Aggressive dominance (SADQ) | 2.6 (0.6) | 2.6 (0.6) | p=0.69 | |
Depressive symptoms (BDI-II) | 3.5 (3.7) | 3.6 (3.9) | p=0.97 | |
Anxiety symptoms (STAI) | 32.4 (6.6) | 32.4 (7.2) | p=1.0 |
*One subject had an outlying score on the BIS-11. Without outlier: p=0.09.